-
Published26/01/2016
-
Deadline01/03/2016
-
Opening of tenders11/03/2016
-
Awarded10/05/2016
-
Today25/09/2026
Utilities
- indicates text translated automatically in your browsing language
Spain-Barcelona: Vaccines
The purpose of this contraction is the purchase of 1 200 000 doses of anti-influenza vaccine for the 2016-2017 campaign, divided into 9 batches, depending on the type of vaccine and territorial scope:
— Inactivated influenza vaccine of fractionated viruses or surface antigen (H i N) produced from viruses created in embryonated eggs:
Batch 1: Barcelona City,
Batch 2: Tarragona and Costa Poniente,
Batch 3: Girona, Vallès Oriental and Vallès Occidental,
Batch 4: Lleida, Catalunya Central, Barcelona Norte and Maresme,
— Inactivated influenza vaccine, 15 micrograms haemagglutinin, adjuvant or virosomic or intradermal administration vaccine:
Batch 5: Barcelona City,
Batch 6: Tarragona and Costa Poniente,
Batch 7: Girona, Vallès Oriental and Vallès Occidental,
Batch 8: Lleida, Catalunya Central, Barcelona Norte and Maresme – Inactivated influenza vaccine of fractionated viruses or surface antigen (H i N) produced from viruses grown in cell cultures:
Batch 9: Catalonia.
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.